Anti-GCK monoclonal antibody

Pre-made anti-GCK monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GCK/GCK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T87166-Ab-1/ GM-Tg-hg-T87166-Ab-2Anti-Human GCK monoclonal antibodyHuman
GM-Tg-rg-T87166-Ab-1/ GM-Tg-rg-T87166-Ab-2Anti-Rat GCK monoclonal antibodyRat
GM-Tg-mg-T87166-Ab-1/ GM-Tg-mg-T87166-Ab-2Anti-Mouse GCK monoclonal antibodyMouse
GM-Tg-cynog-T87166-Ab-1/ GM-Tg-cynog-T87166-Ab-2Anti-Cynomolgus/ Rhesus macaque GCK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T87166-Ab-1/ GM-Tg-felg-T87166-Ab-2Anti-Feline GCK monoclonal antibodyFeline
GM-Tg-cang-T87166-Ab-1/ GM-Tg-cang-T87166-Ab-2Anti-Canine GCK monoclonal antibodyCanine
GM-Tg-bovg-T87166-Ab-1/ GM-Tg-bovg-T87166-Ab-2Anti-Bovine GCK monoclonal antibodyBovine
GM-Tg-equg-T87166-Ab-1/ GM-Tg-equg-T87166-Ab-2Anti-Equine GCK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T87166-Ab-1/ GM-Tg-hg-T87166-Ab-2; GM-Tg-rg-T87166-Ab-1/ GM-Tg-rg-T87166-Ab-2;
GM-Tg-mg-T87166-Ab-1/ GM-Tg-mg-T87166-Ab-2; GM-Tg-cynog-T87166-Ab-1/ GM-Tg-cynog-T87166-Ab-2;
GM-Tg-felg-T87166-Ab-1/ GM-Tg-felg-T87166-Ab-2; GM-Tg-cang-T87166-Ab-1/ GM-Tg-cang-T87166-Ab-2;
GM-Tg-bovg-T87166-Ab-1/ GM-Tg-bovg-T87166-Ab-2; GM-Tg-equg-T87166-Ab-1/ GM-Tg-equg-T87166-Ab-2
Products NameAnti-GCK monoclonal antibody
Formatmab
Target NameGCK
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GCK monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T87166-Ag-1Recombinant multi-species HXK4/ GCK/ FGQTL3 protein
    ORF Viral VectorvGMAP000134Human GCK Adenovirus particle
    ORF Viral VectorpGMAP000134Human GCK Adenovirus plasmid


    Target information

    Target IDGM-T87166
    Target NameGCK
    Gene ID2645,103988,24385,699728,606490,100037406,616576
    Gene Symbol and SynonymsFGQTL3,GCK,GK,GLK,Gls006,GLUKA,HHF3,HK4,HKIV,Hlb62,HXKP,LGLK,MODY2,PNDM1,RNGK2
    Uniprot AccessionP35557,P17712
    Uniprot Entry NameHXK4_HUMAN,HXK4_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000106633
    Target ClassificationN/A

    The target: GCK, gene name: GCK, also named as FGQTL3, GK, GLK, HHF3, HK4, HKIV, HXKP, LGLK, MODY2. This gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of this gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, this enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, this enzyme is important in glucose uptake and conversion to glycogen. Mutations in this gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.